Roadshow
Transepithelial Delivery System (TDS)
TDS
Our transepithelial technology platform enables the transdermal or transmucosal delivery of small chemical drugs. Pushing beyond the boundary of past restrictions with collective strength, TAHO's scientists are creating novel patches and oral films to bridge the gap in conventional medicine. Some advantages of transepithelial delivery include:
- Wide range of release profiles (from fast-onset to weekly sustained delivery)
- Avoids GI side-effect and metabolism
- Higher bioavailability
- Effortless medicament for unwilling patient
Join us at BIO 2024, June 3-6 in San Diego, where TAHO Pharmaceuticals Ltd. will be showcasing our cutting-edge solutions and services. We can't wait to connect with you to discuss how we're shaping the future of biotechnology. Find us at Booth 1917. See you there! #BIO2024#TAIWAN PAVILION
TAH4411 – Antiemetic – Ondansetron OD Film
TAH3311 – Anti-Thrombotic – Apixaban Oral Dissolving Film
TAH3341 – Anti-Thrombotic – Apixaban Oral Extend Release Film
TAH2211 – Opioid Addiction – Buprenorphine / Naloxone Sublingual Film
TAH2231 – Opioid Overdose – Naloxone Buccal Film
TAH9901 – ADHD – Methylphenidate Transdermal Patch
TAH9922 – ADHD – Atomoxetine Oral Liquid
- #drug delivery
- #505(b)(2)
- #anticoagulant
- #opioid
- #ADHD
- #CNS
- #CV
- #cardiovascular
- #buccal
- #sublingual
- Established 2010
- Company TAHO Pharmaceuticals Ltd.
- Telephone +886-2-2659-8515
- Email milkykao@tahopharma.com
- Address 3F., No. 550, Ruiguang Road, Neihu District, Taipei, 11492, Taiwan
Driving Medical Innovation
Bridging The Gap In Current Treatments
Raising Patient Outcomes
TAHO is a commercial-stage specialty pharma pioneering in oral, transdermal drug delivery systems.
Collaborating with our partners across three continents, our pipeline of medicines targets CNS, Geriatric, and Pediatric therapies that provide caregivers with significant treatment options. From concept to commercial, we have several products launched in major markets. Trusted by partner pharma, we devote toward partner value and innovation.